109054 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides against enzymes
Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor
#2402DELIVERY MOLECULES FOR THERAPEUTICS
#2403BIOMARKERS FOR CANCER CHARACTERIZATION AND TREATMENT
#24042′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use
#2405Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
#2406Composition for prophylaxis or treatment of vascular or cardiac valvular calcification comprising dipeptidyl peptidase-4 inhibitor
#2407Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD
#2408METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM
#2409Neurofibromatoses therapeutic agents and screening for same
#2410Visfatin therapeutic agents for the treatment of acne and other conditions
#2411REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#2412METHOD FOR INHIBITING CELL GROWTH, NUCLEIC ACID MOLECULE HAVING RNA INTERFERENCE EFFECT ON NEK10 VARIANT GENE, AND ANTICANCER AGENT
#2413Antisense conjugates for decreasing expression of DMPK
#2414RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA
#2415USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS
#2416Double-stranded oligonucleotides
#2417Methods of treating proliferative disorders with malate or derivatives thereof
#2418INHIBITORS OF NOX4 EXPRESSION AND /OR NOX4 FUNCTION AND THEIR USE IN THE PREVENTION AND TREATMENT OF NERVE INJURY AND/OR NEUROPATHIC PAIN
#2419Delivery of dsRNA to arthropods
#2420Pain treatment
#2421Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
#2422Extended dicer substrate agents and methods for the specific inhibition of gene expression
#2423Extended dicer substrate agents and methods for the specific inhibition of gene expression
#2424Pharmaceutical composition for preventing or treating diabetes containing TENC1 expression or activity suppressor
#2425OLIGONUCLEOTIDE INHIBITORS OF DNA METHYLTRANSFERASES AND THEIR USE IN TREATING DISEASES
#2426Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells
#2427Modulating the interaction between ZO-2/TJP2 and a Snail zinc finger transcription factor family member
#2428METHODS AND COMPOSITIONS FOR MODULATING FACTOR VII EXPRESSION
#2429Methods and compositions for neuroprotection
#2430METHOD FOR PREDICTING AND DETECTING TUMOR METASTASIS
#2431TREATMENT OF UTERINE LEIOMYOMATA
#2432Vitamin B6-coupled poly(ester amine) as gene carrier and application in cancer gene therapy
#2433Increasing taxane sensitivity in cancer cells
#2434Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders
#2435Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
#2436Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP
#2437MODULATION OF BREAST CANCER GROWTH BY MODULATION OF XBP1 ACTIVITY
#2438Treatment of disease by modulation of SIRT6
#2439Inhibition of the glycine cleavage system for treatment of cancer
#2440Compositions and methods to promote erythropoiesis
#2441Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#2442Use of microrna molecules to influence skin pigmentation
#2443Cottonseed oil and uses
#2444Use of human NLK gene and associated drugs thereof
#2445ADAM12 inhibitors and their use against inflammation-induced fibrosis
#2446Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer
#2447Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#2448Transgenic plants modified for reduced cadmium transport, derivative products, and related methods
#2449Transcriptional repression leading to parkinson's disease
#2450Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase I in the treatment of disorders
#2451Collateral gene inactivation biomarkers and targets for cancer therapy
#2452Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#2453Double-stranded RNA compounds to CASP2 and uses thereof
#2454Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#2455Amine cationic lipids and uses thereof
#2456METHOD FOR TARGETING VASCULAR RHOJ FOR INHIBITING TUMOR ANGIOGENESIS
#2457Alternative splicing variants of genes associated with prostate cancer risk and survival
#2458Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
#2459Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
#2460Materials and methods related to modulation of mismatch repair and genomic stability by miR-155
#2461RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis
#2462RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
#2463RNAi-mediated inhibition of tumor necrosis factor α-related conditions
#2464Metabolic gene mesenchymal signatures and uses thereof
#2465Pharmaceutical compositions comprising small interfering RNA inhibitors of NOX3
#2466Small interference RNAs, uses thereof and method for inhibiting the expression of plk1 gene
#2467Compositions and methods for inhibiting expression of the PCSK9 gene
#2468Combination therapy for MDS
#2469OLIGONUCLEOTIDE N3'-->P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USE
#2470Exosomes With Transferrin Peptides
#2471COMBINATORIAL METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA
#2472METHODS OF DIAGNOSIS AND TREATMENT OF ENDOPLASMIC RETICULUM (ER) STRESS-RELATED CONDITIONS
#2473Compositions and methods for inhibiting expression of factor VII gene
#2474Methods of identifying and using MDM2 inhibitors
#2475CNS targeting AAV vectors and methods of use thereof
#2476Polypeptides having beta-glucosidase activity and polynucleotides encoding same
#2477MODULATION OF AXON DEGENERATION
#2478Lin28-mediated control of let-7 biogenesis
#2479METHODS AND COMPOSITIONS FOR TREATING DISEASES, DISORDERS OR INJURY OF THE NERVOUS SYSTEM
#2480PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition
#2481Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same
#2482Methods for treating obesity
#2483Methods for treating chronic pain
#2484PARP-1 INHIBITORS
#2485METHODS OF TREATING CANCER
#2486CASPASE 9 INHIBITION AND BRI2 PEPTIDES FOR TREATING DEMENTIA
#2487Method of treating a metabolic disorder induced by obesity in a subject in need thereof by administering MK2/3 inhibitors
#2488MODULATION OF HISTONE DEACETYLASES FOR THE TREATMENT OF METABOLIC DISEASE, METHODS AND COMPOSITIONS RELATED THERETO
#2489Treatment for neurodegenerative diseases
#2490Therapeutic compositions
#2491Modulation of TMPRSS6 expression
#2492Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#2493ANTISENSE OLIGONUCLEOTIDES AGAINST cPLA2, COMPOSITIONS AND USES THEREOF
#2494Lipids and lipid compositions for the delivery of active agents
#2495Genetic alterations in glioma
#2496Compositions and methods for cancer and cancer stem cell detection and elimination
#2497Inhibitors of metastasis
#2498Induction of thyroid iodide-handling gene expression in human cancers
#2499METHODS AND COMPOSITIONS RELATING TO POLYPEPTIDES WITH RNASE III DOMAINS THAT MEDIATE RNA INTERFERENCE
#2500Means and methods for treating and/or preventing natural AHR ligand-dependent cancer
#2501TARGET DIRECTED TO ADIPOCYTES, METHODS AND ASSAYS FOR TREATMENT OF OBESITY
#2502Methods of treating cancer
#2503Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
#2504PLANTS WITH DECREASED ACTIVITY OF A STARCH DEPHOSPHORYLATING ENZYME
#2505COMPOSITIONS AND METHODS OF USE OF ACC OXIDASE POLYNUCLEOTIDES AND POLYPEPTIDES
#2506MODULATORS OF PHARMACOLOGICAL AGENTS
#2507Antisense oligonucleotides against neutral sphingomyelinase and neutral sphingomyelinase inhibitor GW4869 for degenerative neurological disorders
#2508Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#2509METHODS OF USE OF GLUTAMINE SYNTHETASE INHIBITORS
#2510INCREASING THE LIPID CONTENT IN MICROALGAE BY GENETICALLY MANIPULATING A TRIACYLGLYCEROL (TAG) LIPASE
#2511ACTIVATION OF FUNCTIONAL NUCLEIC ACID BY SPECIFIC MODIFICATION
#2512MEDICAMENT FOR DISEASES ASSOCIATED WITH AMYLOID beta AND SCREENING THEREOF
#2513Methods for treating polyps
#2514COMPLEMENT INHIBITION FOR IMPROVED NERVE REGENERATION
#2515Use of leucyl tRNA synthetase
#2516Compositions and methods for silencing aldehyde dehydrogenase
#2517THE USE OF ACHE AS NUCLEASE
#2518METHODS FOR IMPROVING CARDIAC CONTRACTILITY
#2519Treatments for
#2520Clusterin antisense therapy for treatment of cancer
#2521VHZ for diagnosis and treatment of cancer
#2522Antisense modulation of PTP1B expression
#2523HUNK, A SNF1-RELATED KINASE ESSENTIAL FOR MAMMARY TUMOR METASTASIS
#2524Methods and compositions for reducing amyloid beta levels
#2525Method for therapeutic angiogenesis
#2526Methods of introducing dsRNA to plant seeds for modulating gene expression
#2527Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
#2528TARGETS FOR TREATMENT OF ER STRESS
#2529Methods for modulating factor 12 expression
#2530COMPOUNDS AND METHODS FOR TREATING INSULIN RESISTANCE SYNDROME
#2531Methods of Treating Herpesvirus Infections
#2532Somatic mutations in ATRX in brain cancer
#2533Ameliorating oxidative stress in neurodegenerative disease via Nox1 targeting
#2534Methods for treating Niemann-Pick type C disease
#2535Methods for modulating kallikrein (KLKB1) expression
#2536METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING LYMPHOID MALIGNANCY
#2537COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEPSIS AND OTHER DISORDERS INVOLVING PHOSPHOLIPASE A2 INDUCTION
#2538Methods for treatment of cancer by targeting Sirt5
#2539Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
#2540Targeting the steroidogenic pathway for treating and/or preventing allergic diseases
#2541Methods for modulating kallikrein (KLKB1) expression
#2542Compositions and methods for treating colon cancer
#2543Inhibitors of Cathepsin S for Prevention or Treatment of Obesity-Associated Disorders
#2544Methods for treating hypercholesterolemia
#2545Compositions and methods for inhibiting expression of TMPRSS6 gene
#2546Interfering RNA delivery system and uses thereof
#2547Methods used in sensitizing invasive glioblastoma to therapeutic treatment
#2548Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (ARG)
#2549ANTISENSE OLIGONUCLEOTIDE MODULATION OF RAF GENE EXPRESSION
#2550Cochleate compositions directed against expression of proteins
#2551Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#2552Methods and Compositions for Normalization of Tumor Vasculature by Inhibition of LOXL2
#2553CANCER-CELL-SPECIFIC CYTOSTATIC AGENT
#2554METHODS AND COMPOSITIONS REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
#2555pRNA multivalent junction domain for use in stable multivalent RNA nanoparticles
#2556Role of ADAM10 and its relevance to disease and therapeutics
#2557MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY
#2558Methods and compositions for gene-specific demethylation by DNA methyltransferase (DNMT)-RNA interaction
#2559Composition for inhibiting angiogenesis containing a peroxidasin inhibitor as an active ingredient
#2560RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders
#2561METHODS FOR TREATING IMMUNOSUPPRESSION
#2562PRESERVATION OF THE NEUROMUSCULAR JUNCTION (NMJ) AFTER TRAUMATIC NERVE INJURY
#2563Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
#2564Oligonucleotide Inhibitors with Chimeric Backbone and 2-Amino-2'-Deoxyadenosine
#2565Platelet derived growth factor receptor supports cytomegalovirus infectivity
#2566METHODS FOR TREATING INFLAMMATORY AUTOIMMUNE DISORDERS
#2567Methods and compositions for selecting siRNA of improved functionality
#2568Compositions and methods of preventing or ameliorating abnormal thrombus formation and cardiovascular disease
#2569Medicament for liver regeneration and for treatment of liver failure
#2570QSOX1 as an Anti-Neoplastic Drug Target
#2571Combination therapy
#2572Composition for controlling chromogenesis including microRNA
#2573Method of treatment of breast cancers over-expressing the SHP2 signature genes
#2574SUGAR CHAIN-RELATED GENE AND USE THEREOF
#2575LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENE
#2576Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
#2577Method of treating cancer by inhibition of DNA repair proteins
#2578Compound and method for treating myotonic dystrophy
#2579Polypeptides having xylanase activity and polynucleotides encoding same
#2580Polypeptides having beta-glucosidase activity and polynucleotides encoding same
#2581RNA interference mediated inhibition of isocitrate dehydrogenase (IDH1) gene expression
#2582Methods and compositions for extending shelf life of plant products
#2583Modified siRNA molecules incorporating 5-fluoro-2′-deoxyuridine residues to enhance cytotoxicity
#2584Melatonin-based treatment and diagnosis of bile duct disease
#2585Bruton's tyrosine kinase as anti-cancer drug target
#2586COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES
#2587Prostate carcinogenesis predictor
#2588Method of screening for chaperonin modulator
#2589dsRNA for treating viral infection
#2590Polynucleotide molecules for gene regulation in plants
#2591Nucleic acid aptamers
#2592Compositions and methods for treatment of melanoma
#2593Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease
#2594Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1
#2595Antagonists Of The Oncongenic Activity Of The Protein MDM2, And Use Thereof In the Treatment of Cancers
#2596Compositions and methods for increasing erythropoietin (EPO) production
#2597Methods and compositions for the treatment of eye disorders with increased intraocular pressure
#2598Polynucleotide molecules for gene regulation in plants
#2599Compositions and methods for treating leukemia
#2600Detection of mutations in a gene associated with resistance to viral infection, OAS1
#2601SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer
#2602Biological inhibitors of ROR1 capable of inducing cell death
#2603Identification and use of target genes for control of plant parasitic nematodes
#2604Methods and compositions for inhibiting the proliferation of cancer cells
#2605Method for suppressing receptor tyrosine kinase-mediated pro-survival signaling in cancer cell
#2606Method of enhancing miR-185 expression to reduce low density lipoprotein/cholesterol accumulation in a cell
#2607Methods for modulating factor 12 expression
#2608Metabolic gene, enzyme, and flux targets for cancer therapy
#2609Compositions and methods for inhibiting expression of the PCSK9 gene
#2610METHODS AND COMPOSITIONS FOR WEED CONTROL
#2611DOUBLE STRANDED OLIGONUCLEOTIDE COMPOUNDS COMPRISING POSITIONAL MODIFICATIONS
#2612Production and utilization of a novel anti-cancer drug in therapy
#26135′-end derivatives
#2614Mammalian Genes Involved in Infection
#2615Methods and compositions for weed control
#2616Lipid nanoparticle compositions for antisense oligonucleotides delivery
#2617Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of brain tumors
#2618Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer
#2619Oligonucleotide compositions with enhanced efficiency
#2620Targeting metabolic enzymes in human cancer
#2621Compositions and Methods for Inhibition of PCSK9 Genes
#2622Antisense antibacterial method and compound
#2623QSOX1 as an anti-neoplastic drug target
#2624Multicistronic expression constructs
#2625Compositions and methods for inhibiting expression of the ALAS1 gene
#2626Mitochondrial targeted RNA expression system and use thereof
#2627SiRNA against p22phox
#2628Compositions and methods for inhibiting expression of Eg5 gene
#2629Modulation of factor 11 expression
#2630COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION
#2631Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (DCIR) activity and signaling events
#2632METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING BIFUNCTIONAL SRC 3 shRNA
#2633METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC 3 shRNA
#2634Methods and compositions for weed control
#2635Methods and compositions for weed control
#2636Targeting of CYP1B1 in the treatment of head and neck cancer and lung cancer
#2637Methods and compositions for weed control
#2638METHOD TO REDUCE THE CONTENT OF UNSATURATED FATTY ACIDS IN LATEX RECOVERED FROM PARTHENIUM ARGENTATUM OR TARAXACUM KOK-SAGHYZ
#2639Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
#2640Treatment of sialidase 4 (NEU4) related diseases by inhibition of natural antisense transcript to NEU4
#2641Methods of treating obesity by inhibiting nicotinamide N-methyl transferase (NNMT)
#2642MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION
#2643METHOD AND COMPOSITION FOR THE TREATMENT, PREVENTION, AND DIAGNOSIS OF CANCER CONTAINING OR DERIVED FROM CANCER STEM CELLS
#2644Nucleic acid having an anti-metabolic syndrome effect
#2645Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application
#2646Adeno-associated virus vector for gene transfer to nervous system cells
#2647Methods and compositions for the inhibition of fructokinase
#2648Down-regulation of gene expression using artificial MicroRNAs for silencing fatty acid biosynthetic genes
#2649Modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
#2650Cancer therapy
#2651Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
#2652Methods and compositions for malic enzyme 2 (ME2) as a target for cancer therapy
#2653Inhibitory RNAs to RNA binding proteins hnRNPA1, hnRNPA2 and PTB and uses thereof
#2654Targeted particles comprising landscape phage fusion proteins and heterologous nucleic acid
#2655Inhibiting striated muscle activator of RHO (stars) to improve glycemic control
#2656Inhibition of PCSK9 through RNAi
#2657Double-stranded RNA oligonucleotides which inhibit tyrosinase expression
#2658CNS targeting AAV vectors and methods of use thereof
#2659Method for modulating double-strand break-induced homologous recombination
#2660MODULATION OF FACTOR 11 EXPRESSION
#2661NUCLEIC ACID COMPOUNDS WITH CONFORMATIONALLY RESTRICTED MONOMERS AND USES THEREOF
#2662Compositions and methods for inhibiting expression of factor VII gene
#2663Dual targeting siRNA agents
#2664Fusion polypeptide comprising NtHMA transporter
#2665Polypeptides having beta-glucosidase activity and polynucleotides encoding same
#2666Methods and compositions for the inhibition of Stat5 in prostate cancer cells
#2667Polypeptides having xylanase activity and polynucleotides encoding same
#2668In vivo gene silencing by chemically modified and stable siRNA
#2669Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient
#2670RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)
#2671Compounds and methods for modulating expression of DGAT2
#2672Bladder cancer tumor marker, antibody and use thereof
#2673Regulators of NFAT and/or store-operated calcium entry
#2674EML4-ALK fusion gene
#2675Compositions and methods for treating cancer and modulating stress granule formation
#2676Double stranded RNA compounds to RhoA and use thereof
#2677WHSC1 AND WHSC1L1 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS
#2678Double-stranded RNA-based nanoparticles for insect gene silencing
#2679MLK4 gene, a new diagnostic and prognostic marker in cancers
#2680CANCER-CELL-SPECIFIC CYTOSTATIC AGENT
#2681GDE Compositions and Methods
#2682TREATMENT OF DIABETES AND DISORDERS ASSOCIATED WITH VISCERAL OBESITY WITH INHIBITORS OF HUMAN ARACHIDONATE 12 LIPOXYGENASE AND ARACHIDONATE 15-LIPOXYGENASE
#2683Compositions and methods for inhibiting expression of Mylip/Idol gene
#2684Modulation of diacylglycerol acyltransferase 2 expression
#2685COMPOSITION FOR PREVENTING OR TREATING DIABETES COMPRISING NAD GLYCOHYDROLASE INHIBITOR AS ACTIVE INGREDIENT
#2686Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1
#2687Method for transfecting nucleic acid to cell and nucleic acid complex
#2688METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
#2689COMPOSITIONS AND THEIR USES DIRECTED TO ACEYTL-COA CARBOXYLASES
#2690Baculovirus-mediated transgene expression in both mammalian and insect cells
#2691METHODS AND COMPOSITIONS RELATED TO MODIFIED ADENOSINES FOR CONTROLLING OFF-TARGET EFFECTS IN RNA INTERFERENCE
#2692SIRT4 activities
#2693Methods involving aldose reductase inhibitors
#2694Compositions and methods for treating neurological disorders
#2695FUNGAL PROTEASES
#2696Treatment of methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA
#2697Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT)
#2698Glucose valve and other metabolite valves
#2699Mammalian Genes Involved in Tularemia and Other Infections
#2700Modified oligonucleotides for telomerase inhibition